Cargando…
Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323349/ https://www.ncbi.nlm.nih.gov/pubmed/35910664 http://dx.doi.org/10.1002/trc2.12344 |
| _version_ | 1784756528705699840 |
|---|---|
| author | Manyara, Anthony Muchai Ciani, Oriana Taylor, Rod S. |
| author_facet | Manyara, Anthony Muchai Ciani, Oriana Taylor, Rod S. |
| author_sort | Manyara, Anthony Muchai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9323349 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93233492022-07-30 Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers Manyara, Anthony Muchai Ciani, Oriana Taylor, Rod S. Alzheimers Dement (N Y) Reply John Wiley and Sons Inc. 2022-07-26 /pmc/articles/PMC9323349/ /pubmed/35910664 http://dx.doi.org/10.1002/trc2.12344 Text en © 2022 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Reply Manyara, Anthony Muchai Ciani, Oriana Taylor, Rod S. Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers |
| title | Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers |
| title_full | Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers |
| title_fullStr | Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers |
| title_full_unstemmed | Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers |
| title_short | Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers |
| title_sort | reply to commentary by cummings (2022): surrogate endpoints extend beyond biomarkers |
| topic | Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323349/ https://www.ncbi.nlm.nih.gov/pubmed/35910664 http://dx.doi.org/10.1002/trc2.12344 |
| work_keys_str_mv | AT manyaraanthonymuchai replytocommentarybycummings2022surrogateendpointsextendbeyondbiomarkers AT cianioriana replytocommentarybycummings2022surrogateendpointsextendbeyondbiomarkers AT taylorrods replytocommentarybycummings2022surrogateendpointsextendbeyondbiomarkers |